Sales & Marketing News | pharmaphorum

News

Closeup of X-ray photography of human brain

Biogen shares pop as it completes filing for Alzheimer's dru...

Biogen’s share price was up sharply on Wednesday after the big pharma completed its filing of its Alzheimer’s Disease (AD) drug aducanumab with the FDA.

News

Amgen's cancer biosimilars stay on US market as court battle...

Amgen has scored yet another home run in the US courts, this time seeing off a legal challenge from Genentech, which was trying to block it from launching two cut-price cancer biosimilars.

News

FDA grants fast review of AZ's Brilinta to prevent recurring...

The FDA has granted a fast review of AstraZeneca’s cardiovascular diseases drug Brilinta (ticagrelor) in the new indication that aims to reduce the chances of patients having recurring stro

News

European Commission approves Gilead's remdesivir for COVID-1...

The European Commission has conditionally approved Gilead’s remdesivir for treatment of COVID-19, the first drug officially cleared for use against the disease by EU regulators.

News

Male Doctor In Office Working At Computer

Payments from UK pharma to healthcare professionals increase...

The UK’s pharmaceutical industry has published headline figures from its Disclosure UK scheme, showing payments from pharma to healthcare professionals increased in 2019.

News